Drug and Alcohol Dependence
Volume 86, Issue 1 , Pages 30-36 , 5 January 2007

A randomized controlled trial of interim methadone maintenance: 10-Month follow-up

  • Robert P. Schwartz

      Affiliations

    • Friends Research Institute Inc., 1040 Park Avenue, Suite 103 Baltimore, MD 21201, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 410 837 3977; fax: +1 410 752 4218.
  • ,
  • Jerome H. Jaffe

      Affiliations

    • University of Maryland School of Medicine, 701 W. Pratt St., Baltimore, MD 21201, United States
  • ,
  • David A. Highfield

      Affiliations

    • Friends Research Institute Inc., 1040 Park Avenue, Suite 103 Baltimore, MD 21201, United States
  • ,
  • Jason M. Callaman

      Affiliations

    • Friends Research Institute Inc., 1040 Park Avenue, Suite 103 Baltimore, MD 21201, United States
  • ,
  • Kevin E. O’Grady

      Affiliations

    • Department of Psychology, University of MD, College Park, MD 20742, United States

Received 24 February 2006 ,Revised 21 April 2006 ,Accepted 25 April 2006.

References 

  1. Ball J, Ross A. The Effectiveness of Methadone Maintenance Treatment. New York: Springer-Verlag; 1991;
  2. Bell J, Burrel T, Indig D, Gilmour S. Cycling in and out of treatment; participation in methadone treatment in NSW, 1990–2002. Drug Alcohol Depend. 2006;81:55–61
  3. Buning EC, Van Brussel GH, Van Santen G. The “methadone by bus” project in Amsterdam. Br. J. Addict. 1990;85:1247–1250
  4. Cooper JR. Methadone treatment and acquired immunodeficiency syndrome. JAMA. 1989;262:664–1682
  5. D’Aunno T, Folz-Murphy N, Lin X. Changes in methadone treatment practices: results from a panel study, 1988–1995. Am J Drug Alcohol Abuse. 1999;25(4):681–699
  6. Des Jarlais DC, Paone D, Friedman SR, Peyser N, Newman RG. Regulating controversial programs for unpopular people: methadone maintenance and syringe exchange programs. Am. J. Public Health. 1995;85:1577–1584
  7. Dole VP. Interim methadone clinics: an undervalued approach. Am. J. Public Health. 1991;81(9):111–112
  8. Federal Register, title 21, 1993. Codified at 58 CFR 496, pt 291.
  9. Friedman P, Des Jarlais DC, Peyser NP, Nichols SE, Drew E, Newman RG. Retention of patients who entered methadone maintenance via an interim methadone clinic. J. Psychoactive Drugs. 1994;26(2):217–221
  10. Glasscote R, Sussex JN, Jaffe JH, Ball J, Brill L. The Treatment of Drug Abuse: Programs, Problems, Prospects. Washington, DC: Joint Information Service; 1972;pp. 127–151
  11. Gossop M, Marsden J, Stewart D, Lehmann P, Strang J. Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: results from the National Treatment Outcome Research Study. Br. J. Gen. Pract. 1999;49:31–34
  12. Hotham E, Roche A, Skinner N, Dollman B. The general practitioner pharmacotherapy prescribing workforce: examining sustainability from a systems perspective. Drug Alcohol. Rev. 2005;24:393–400
  13. Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotic addicts. Arch. Gen. Psych. 2001;58:503–508
  14. Johnson RE, Jaffe JH, Fudala PJ. A controlled trial of buprenorphine treatment for opioid dependence. JAMA. 1992;267(20):2750–2755
  15. Lewis DC. Access to narcotic treatment and medical care: prospects for the expansion of methadone maintenance treatment. J. Addict. Dis. 1999;18:5–21
  16. Ling W, Wesson DR, Varuvastra C, Klett J. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch. Gen. Psychiatry. 1996;5:401–407
  17. Mattick, R.P., Digiusto, E., Doran, C., O’Brien, S., Shanahan, N., Kimber, J., Henderson, N., Breen, C., Shearer, J., Gates, J., Shakeshaft, A., NEPOD Trial Investigators, 2001. National evaluation of pharmacotherapies for opioid dependence (NEPOD): report of results and recommendations. Monograph Series Number 2, National Drug and Alcohol Research Centre, Sydney.
  18. McLellan AT, Luborsky L, Woody GE, O’Brien CP. An improved diagnostic evaluation instrument for substance abuse patients: the addiction severity index. J. Nerv. Ment. Dis. 1980;168:26–33
  19. McLellan AT, Luborsky L, Cacciola JS, Griffin J, Evans F, Barr HL, et al. New data from the ASI: reliability and validity in three center. J. Nerv. Ment. Dis. 1985;173:412–423
  20. McLellan AT, Arndt IO, Metzger DS, Woody GE, O’Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA. 1993;269(15):1953–1959
  21. Metzger D, Woody GE, McLellan AT, O’Brien CP, Druley P, Navaline H, et al. HIV seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J. Acq. Immune Def. Synd. 1993;6:1049–1056
  22. Newman RG, Peyser N. Methadone treatment: experiment and experience. J. Psychoactive Drugs. 1991;23(2):115–121
  23. Platt JJ, Widman M, Lidz V, Marlowe D. Methadone maintenance treatment: its development and effectiveness after 30 years. In:  Inciardi JA,  Harrison LD editor. Heroin in the Age of Crack-Cocaine. Thousand Oaks, CA: Sage Publications; 1998;p. 160–187
  24. Schwartz RP, Highfield DA, Jaffe JH, Brady JV, Butler CB, Rouse CO, et al. A randomized controlled trial of interim methadone maintenance. Arch. Gen. Psychiatry. 2006;63(1):102–109
  25. Sees KL, Delucchi KL, Masson C, Rosen A, Clark HW, Robillard H, et al. Methadone maintenance vs. 180-day psychosocially enriched detoxification for treatment of opioid dependence. A randomized controlled trial. JAMA. 2000;283(10):1303–1309
  26. Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Comparison of buprenorphine and methadone in the treatment of opioid dependence. Am. J. Psychiatry. 1994;151:1025–1030
  27. Sullivan LE, Metzger DS, Fudala PJ, Fiellin DA. Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. Addiction. 2005;11:150–158
  28. Yancovitz SR, Des Jarlais DC, Peyser NP, Drew E, Friedmann P, Trigg HL, et al. A randomized trial of an interim methadone maintenance clinic. Am. J. Public Health. 1991;81:1185–1191

PII: S0376-8716(06)00192-X

doi: 10.1016/j.drugalcdep.2006.04.017

Drug and Alcohol Dependence
Volume 86, Issue 1 , Pages 30-36 , 5 January 2007